DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 20 filers reported holding AKARI THERAPEUTICS PLC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2017$1,082,000
-59.4%
249,785
-42.4%
0.04%
-64.2%
Q3 2017$2,662,000
-29.4%
433,551
-47.0%
0.12%
-40.3%
Q2 2017$3,772,000
-70.4%
818,158
-28.9%
0.20%
-59.1%
Q1 2017$12,738,000
+57.2%
1,150,7000.0%0.49%
+47.4%
Q4 2016$8,101,000
-17.3%
1,150,7000.0%0.33%
-26.8%
Q3 2016$9,792,000
-36.9%
1,150,7000.0%0.46%
-25.4%
Q2 2016$15,523,000
-3.6%
1,150,7000.0%0.61%
-11.1%
Q1 2016$16,110,000
-3.4%
1,150,7000.0%0.69%
+1.5%
Q4 2015$16,685,000
-39.6%
1,150,7000.0%0.68%
-36.7%
Q3 2015$27,611,0001,150,7001.07%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q4 2015
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 4,103,098$2,585,0003.26%
Omnia Family Wealth, LLC 782,372$493,0000.40%
ARMISTICE CAPITAL, LLC 4,290,000$2,703,0000.05%
Bryn Mawr Capital Management, LLC 100,000$63,0000.02%
NEA Management Company, LLC 452,167$285,0000.01%
Hikari Power Ltd 130,821$82,0000.01%
Truvestments Capital LLC 1,621$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$19,0000.00%
MILLENNIUM MANAGEMENT LLC 37,544$24,0000.00%
Renaissance Technologies 40,050$25,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders